What Is Medical Device Sales and Why Your First Rep Stalls Without Category Design

What is medical device sales? It's the work of teaching a hospital to adopt a clinical product. Then it's guiding that purchase through people who each judge it differently.

A rep can only do that in a market that already understands the category. When founders skip that step, the first sales hire spends the year explaining the problem instead of selling the device.

Key Takeaways

• Medical device sales starts with clinician trust and ends with hospital approval. Every deal has two audiences: the physician who wants the device and the institution that pays for it.
• Bruce Cleveland names the common failure. Companies skip market development before FDA clearance, then hire a sales team the day it arrives.
• Justin Poulin warns that an early product evaluation can stall for a month if nobody manages the supply chain relationship.
• Rick Barnett recommends three to five reps in the cities where you can get lift, not 15 across the map.
• A software playbook of one demo and one decision maker breaks in a hospital, where supply chain, finance, and a review committee each hold a veto.
• MarketCraft sequences category design, then messaging, then narrative before the first hire, so hospitals pull the device instead of a rep pushing it.

What Is Medical Device Sales and How the Process Works

Medical device sales is clinical education that ends in a hospital purchase. A rep teaches clinicians how the device changes a procedure, then supports the approvals that follow.

The medical device sales process moves through clinical interest, evaluation, committee review, and contracting, and each stage has a different buyer.

The first stage is clinical. A rep earns credibility with the physician who will use the device. That means knowing the procedure, the outcomes data, and the objections a clinician will raise. That trust is the asset.

Without it, the rest of the process never starts.

The second stage is institutional. Once a clinician wants the device, the hospital has to approve it. Supply chain, finance, and a review committee each ask their own question. None of them fell in love with the technology.

So the rep works two conversations at once. One is with the clinician about outcomes. The other is with the institution about cost, contracting, and disruption to how the hospital already buys.

That's why the process runs on a slower clock than software. A demo can create interest in an afternoon. It can't move a purchase through a committee.

FDA clearance is the starting line, not the finish line. Clearance says the device may be sold, and it says nothing about whether a hospital will buy it. I cover that gap in the medtech commercialization strategy guide.

How Hospital Buying Differs From Selling Software

Hospital buying differs from software buying because the person who wants the product is rarely the person who approves it. A surgeon can champion a device for months while supply chain, finance, and a review committee decide whether it enters the building at all.

The rep has to earn every one of those approvals.

Software founders tend to bring one model to this. A fast demo, one decision maker, a close date. I see the same pattern in first-time medtech founders who hire from software and expect the playbook to transfer.

It rarely transfers. A demo doesn't answer a value analysis committee, and a champion who loves the device doesn't sign the contract. I break down the difference in how market engineering changes what medical device sales requires.

I interviewed Justin Poulin on an episode about how to influence hospital supply chain in medical sales. Justin described how an early evaluation can stall:

"When you go through supply chain, even when you're dealing with a trial of a product or an evaluation, that relationship, if you don't manage it early on, could be something that holds your deal up for a month."

A month of delay sounds small until you count what it costs a company with limited runway. It also makes the larger point. The institution is a buyer, and it needs its own relationship from the first day of the evaluation.

Why a First Sales Rep Stalls Before the Category Exists

A first sales rep stalls when the market doesn't yet understand the category the device belongs to. The rep ends up explaining the problem to every clinician instead of selling a solution to one.

That's a category design gap, and no amount of selling skill closes it from the field.

I interviewed Bruce Cleveland on an episode about product-market fit and category design. Bruce said:

"They go through this period pre-FDA where they don't really have a sales team. You might have one sales leader, but you have time.

But they don't spend the time nurturing and developing the market. Then the moment they get FDA clearance, they hire a sales team to hit the streets, assuming there's a market to sell to."

That sequence matches what I've watched play out again and again in 400+ episodes of The State of MedTech. Founders treat the pre-FDA years as waiting time.

Clearance arrives, the sales hire follows, and the market that was supposed to be waiting turns out to be unformed.

A capable rep in an unformed market still spends the year on education, because the buyer has no shared language to recognize. Sales and marketing get blamed. The missing pieces sit upstream, in the category, the messaging, and the narrative.

I call this the traction gap. Clinical validation doesn't equal commercial traction, and a first rep can't bridge that gap alone. For the full sequence, see the five pillars of market engineering.

I interviewed Rick Barnett, Founder of Rep-Lite, on an episode about what is wrong with medical sales hiring today. Rick made the case for hiring small and sequencing the rest:

"It's go out and hire three or five in the cities that you think you can get lift on, get those running, and then start picking off different areas."

Small and sequenced beats broad and early. Three to five reps only work when the category is already legible to the buyers in those cities. I go deeper on the hiring side in what US Surgical knew about medical device sales reps.

What This Means for Medtech Founders

In my experience working with medtech founders, the most useful move before the first sales hire is to ask what that person will be selling into. If the honest answer is a category the buyer can't yet name, the work belongs upstream.

That's the market engineering layer MarketCraft builds first. It starts with the category, then the messaging, then the narrative.

Before you write the job description, test three things. Can a clinician describe the problem in your words? Do you know who approves the purchase after the champion says yes? Have you started the supply chain relationship before the evaluation begins?

If the answers are no, the first hire should wait. Pull-driven demand, where hospitals ask for the device, is what lets a first rep sell instead of teach. Great companies don't wait for markets to form. They engineer them.

The same logic applies to how you structure the team. The three stages of building a medical device sales organization show which decisions come first and which can wait until the market is ready.

Frequently Asked Questions

What is medical device sales?

Medical device sales is the process of educating clinicians about a device and guiding the hospital through the purchase.

A rep builds clinical credibility with the physician who will use the product, then supports the supply chain, finance, and committee approvals that decide whether the hospital buys it, from first evaluation to final contract.

How is medical device sales different from software sales?

Medical device sales involves at least two audiences: the clinician who wants the device and the institution that approves the purchase. Software deals often close with a single decision maker after a demo.

A device rep has to earn clinical trust first, then move the purchase through hospital review, which takes longer and involves more people.

What does a medical device sales rep do?

A medical device sales rep teaches clinicians how the device fits their procedures, answers outcomes questions, and supports the evaluation. The rep also works with hospital supply chain and finance so the purchase can clear approval.

Most of the job is education and relationship building, with the closing steps coming later.

When should a medtech company hire its first sales rep?

Hire the first rep after the category, messaging, and narrative are clear enough that a buyer can name the problem without a lecture. Until then, the rep spends the year educating the market.

Start with a small team in the cities where you can get lift, then expand as the market forms.

What are the biggest medical device sales challenges for a first-time founder?

Hospital approvals move slowly, and buyers often don't know the category yet. A first-time founder feels both hardest after hiring a rep too early, because the rep spends the year teaching the category instead of reaching a contract.

Fixing the category first removes most of that drag.

Where to Go From Here

If you're doing this yourself. Read the medtech commercialization strategy guide to see how the pieces fit before your first hire, then listen to The State of MedTech to hear how other founders sequenced it.

If you want it engineered with you. MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. It's where we check whether your first-rep problem sits upstream in the category or downstream in the sales motion.

Listen to the Full Conversations

The episodes behind this post are available on The State of MedTech. Subscribe wherever you listen to podcasts.

• Bruce Cleveland: The Truth About Product-Market Fit, Category Design & Why Startups Waste Funding
• How to Influence Hospital Supply Chain in Medical Sales with Justin Poulin
• Everything Wrong with Medical Sales Hiring Today with Rick Barnett, Founder of Rep-Lite

About the Author

Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry. He works with medtech founders and commercial leaders on market engineering, commercialisation strategy, and revenue growth.

Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.